SCHEMBL6578628

SCHEMBL6578628

CCOC(=O)c1cn(-c2ccc(F)cc2Cl)c2c(C)c(F)c(F)cc2c1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 3/20 0.52
HTT P42858 1/20 0.46
KMT2A Q03164 2/20 0.43
KDM4E B2RXH2 3/20 0.42
HPGD P15428 3/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
NPC1 O15118 1/20 0.41
HSD17B10 Q99714 2/20 0.40
ADRB2 P07550 1/20 0.40
PIM1 P11309 1/20 0.40
IRAK1 P51617 1/20 0.40
CAMK2B Q13554 1/20 0.40
CAMK2G Q13555 1/20 0.40
CAMK2D Q13557 1/20 0.40
PIM3 Q86V86 1/20 0.40
CMA1 P23946 1/20 0.39
NR3C2 P08235 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7011343 0.94 STAT3 (0.52) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL6578888 0.90 STAT3 (0.54) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL20912620 0.87 STAT3 (0.52) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL7004211 0.87 STAT3 (0.53) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL7004096 0.86 STAT3 (0.52) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL7005414 0.85 KMT2A (0.54) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL10471993 0.85 HTT (0.57) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL31435141 0.85 STAT3 (0.62) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL10472475 0.85 STAT3 (0.62) STAT3HTTKMT2AKDM4EHPGD
SCHEMBL7006394 0.85 STAT3 (0.51) STAT3HTTKMT2AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0897919-B1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMA CO LTD (JP) 2004-06-16 EP disclosed
US-6211375-B1 IMPROVED INTESTINAL ABSORPTION WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 2001-04-03 US disclosed
EP-0897919-A1 NOVEL PYRIDONECARBOXYLIC ACID DERIVATIVES OR SALTS THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THE SAME AS THE ACTIVE INGREDIENT WAKUNAGA PHARMACEUTICAL CO., LTD. (JP) 1999-02-24 EP disclosed